Optogenetics actuators & sensors market is growing significantly and is considered as a recent development in neuroscience that allows the use of optically activated proteins to control neuronal functions. Optogenetics helps in the treatment of various diseases such as Parkinson’s disease, Alzheimer’s diseases, retinal disorders, autism and others. Optogenetics allows the activation or inhibition of neuron with superior degree of spatial, temporal and neurochemical precision. The market witnessed significant growth owing to the increasing prevalence of neurological and retinal disorders resulting in the high demand for optogenetics actuators and sensors.

As per NCBI report (2016), the prevalence of glaucoma over the age of 40 was 2.1% in the US and is increasing at a considerable rate, therefore, increasing the demand for optogenetics actuators and sensors. Moreover, favorable government regulations and consumer awareness towards retinal disorder and neuro-related diseases tend to increase the market share of optogenetics actuators and sensors. Furthermore, changing healthcare reforms coupled with collaboration of government and private companies are expected to lead to technological innovations in optogenetics which in turn accelerate the growth of optogenetics actuators and sensors market.

The optogenetics actuators and sensors industry is segmented on the basis of product type and disease type. Based on the product type, the market is segmented into actuators (Channelrhodopsin, Halorhodopsin Biochip, Archaerhodopsin) and sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors). On the basis of disease type, the market is segmented into retinal disorders, Parkinson's disease, Alzheimer's disease, epilepsy, autism, and others. Alzheimer’s segment is expected to show significant growth over the forecast period owing to rising number of Alzheimer disease related patients across the globe. According to World Alzheimer Report, in 2016, there were approximately 46.5 million Alzheimer disease patients across the globe resulting in the increased demand for optogenetics actuators and sensors.

The major players in the market include Circuit Therapeutics, Inc., Gensight Biologics, Applied Genetic Technologies Corp. (AGTC), The Jackson Laboratory, along with many others. These companies are adopting several strategies, such as merger and acquisitions, product launches, geographical expansion and collaboration, and partnership to expand market share across the globe. For instance, in March 2019, Biogen announced that it has entered into an agreement to acquire Nightstar Therapeutics, a clinical-stage gene therapy company. The acquisition will help the company to expand its product portfolio in gene-therapy programs for retinal disorders.

Research Methodology

The market study of the global optogenetics actuators and sensors market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Optogenetics Actuators and Sensors Market Research and Analysis by Product Type
2. Global Optogenetics Actuators and Sensors Market Research and Analysis by Disease Type

The Report Covers:

• Comprehensive research methodology of the global optogenetics actuators and sensors market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global optogenetics actuators and sensors market.
• Insights about market determinants which are stimulating the global optogenetics actuators and sensors market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.